Here, the authors observed that patients who developed high-grade CRS showed high peak values of e.g. IL-6, IFN-γ and MCP-1 early after CAR-T cell infusion (day 1-3) but also up to day 30 after CAR-T infusion compared to patients who only showed mild CRS symptoms. Here, CCL2 is linked to congenital rubella syndrome.